Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Paul Leeson,
Habitual intake of flavonoid subclasses and incident hypertension in adults Aedín Cassidy, Éilis J O'Reilly, Colin Kay et al Am J Clin Nutr November 2010 ajcn.006783
Dietary intake of bioactive substances that lower blood pressure provides a simple and attractive way for patients to take day-to-day control of their health. Flavonoids are a group of bioactive plant-based substances that have become of interesting interest. In experimental studies they have direct effects on vascular biology, in particular nitric oxide bioavailability, which is likely to explain why they lower blood pressure in clinical studies. However, meta-analysis of randomised controlled trials of flavonoids demonstrates that not all subclasses of flavonoids lower blood pressure. Furthermore, the doses of flavonoids in some trials can not reasonably be achieved with simple dietary advice. So, which flavonoids work and how do people normally eat them in their diet?
Cassidy et al (Am J Clin Nutr 2011;93:338-347) recently addressed these questions using population-based data on diet and incidence of hypertension collected within the two Nurses’ Health Studies and the Health Professionals Follow-Up Study in the United States. They estimated flavonoid intake based on expected flavonoid content of the different foods that participants reported eating. They then related incidence of hypertension to intake of the major flavonoid subclasses. The biggest effect on blood pressure was seen with anthocyanin intake. Those with anthocyanin intake above the top quintile had an 8% decreased risk of hypertension (RR 0.92) compared to those below the bottom quintile for intake. The association was greater in those below 60yrs of age (RR 0.88). No other subclasses of flavonoid associated with risk of hypertension although some specific flavonoids within the subclasses did, namely, apigenin (5% reduction) as well as catechin and epicatechin (7% and 5% reduction respectively).
Which foods contained these flavonoids? The major sources of anthocyanins in the studies were blueberries and strawberries. Consumption of one or more servings of blueberries per week was associated with a 10% reduction in hypertension. Interestingly, however, there may be some complications to the story as a similar effect was not seen with strawberry consumption. As for catechin and epicatechin, these are the main constituents of dark cocoa. Therefore, if you have advised a patient to "eat more fruit and vegetables" but they still want more specific dietary advice about how to prevent hypertension try…. "eat more blueberries and chocolate’".
© 2017 European Society of Cardiology. All rights reserved